Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2006

View Archived Issues

Aerosolized hydroxychloroquine studied in phase II for asthma

Bayer concludes divestment of antiinfectives research to Santo Holding

Orphan drug designation for SLIT Amikacin

American businesses of Sankyo and Daiichi to integrate

Immtech International changes name to Immtech Pharmaceuticals

Vertex and CFFT form new collaboration to develop VX-770 for cystic fibrosis

Samaritan concluding preclinical studies of SP-233 for Alzheimer's disease

Allergan completes acquisition of Inamed

Enrollment completed in phase III study of TH-9507 for HIV lipodystrophy

Phase III hepatorenal syndrome study of terlipressin completes enrollment

Schering AG supports Bayer offer

FDA Advisory Committee recommends against approval of Sparlon for ADHD

TBC-3711 on clinical hold following rat finding

Phase I/II study evaluates nimotuzumab for NSCLC

Idenix modifies phase IIb trials of valopicitabine

Phase II findings for ACP-103 for treatment-induced psychosis in Parkinson's

Orphan drug designation for Aastrom's Tissue Repair Cells in osteonecrosis

Spectrum to acquire oncology drug assets of Targent

Ranexa now available for chronic angina

Approvable letter for Thelin in PAH

In vivo efficacy of a novel CCR3 antagonist for allergic inflammatory disease

Avidex reports new immunomodulatory agents

Recent patents report new therapeutic agents for metabolic disorders

BMS-355249: novel potentiator of NT-3-mediated trk A and trk B activation

Novel LFA-1 antagonist demonstrates biological activity in vivo

Dipyridamole analogue potently inhibits ENT1

Spotlight on prostaglandin E2 EP1 receptors as mediators of neurotoxicity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...